Norris Cotton Cancer Center
From Wikipedia, the free encyclopedia
NCCC is the comprehensive cancer center at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire. It is New Hampshire's only National Cancer Institute designated comprehensive cancer center. Norris Cotton Cancer Center at Catholic Medical Center opened February 2008.[1]
NCCC is named for former U.S. Senator Norris Cotton, who in 1970, secured a $3 million federal grant to establish the first cancer center in northern New England. NCCC has been National Cancer Institute designated since 1978. Cancer research at NCCC is conducted by more than 100 investigators in more than 250 projects totalling over $50 million in annual funding. NCCC also serves more than 20,000 cancer patients per year.
Mark A. Israel, formerly of UCSF, is a molecular biologist and pediatric oncologist who serves at NCCC Director.
As a comprehensive cancer center, NCCC is engaged in clinical research, population sciences and basic sciences. Burton L. Eisenberg, a surgical oncologist, is Associate Director for Clinical Research. Allen Dietrich, a behavioral scientists and member of the National Academy of Sciences' Institute of Medicine, is Associate Director for Population Sciences. Charles Brenner, a geneticist and biochemist interested in enzyme function in tumor suppression, is Associate Director for Basic Sciences.
NCCC research is conducted in 6 scientific programs. Cancer Control is directed by James Sargent, a pediatrician with a research program on the effect of watching smoking in the movies. Cancer Epidemiologist and Chemoprevention is jointly directed by Ethan Dmitrovsky, an oncologist and researcher on the mechanisms of lung carcinogenesis and acute promyelocytic leukemia, and Margaret Karagas, a cancer epidemiologist. Cancer Mechanisms is directed by Duane Compton, a cell biologist interested in chromosome instability. Molecular Therapeutics is directed by Alan Eastman, a pharmacologist interested in action of chemotherapy agents vis a vis the cell division cycle. Immunology and Cancer Immunotherapy is directed by Randolph J. Noelle, an immunologist who has made strides toward the development of cancer immunotherapeutics. Radiobiology and Bioengineering is co-directed by Keith D. Paulsen, an engineer who develops new breast imaging technologies, and Harold M. Swartz, an electron paramagnetic resonance spectroscopist who develops novel approaches to measure oxygen in tumors and for animal tumor imaging.
